Trospium
From Wikipedia, the free encyclopedia
Trospium
|
|
Systematic (IUPAC) name | |
3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-Spiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] | |
Identifiers | |
CAS number | |
ATC code | G04 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C25H30NO3 |
Mol. mass | 392.511 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 50-85% |
Metabolism | ? |
Half life | 20 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
'Trospium is a urinary antispasmodic. It is sold under the brand name Sanctura in the US, Trosec in Canada, Regurin in the United Kingdom and Spasmex in Israel.
|